Form 4 for ZLAB Zai Lab Ltd
Accepted 2021-08-25 00:00:00 ET · period of report 2021-08-23 · accession 0001567619-21-016336 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-25 | 2021-08-23+ | ZLAB | Reinhart Harald | Chief Medical Off | M - OptEx | $17.99 | +16.0K | 8,000 | New | +$287.8K |
| DM | 2021-08-25 | 2021-08-23+ | ZLAB | Reinhart Harald | Chief Medical Off | S - Sale+OE | $139.18 | -16.0K | 0 | -100% | -$2.23M |
| DM | 2021-08-25 | 2021-08-23+ | ZLAB | Reinhart Harald | Chief Medical Off | M - OptEx | $0.00 | -16.0K | 30.0K | -35% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-08-23 | M | A | 8,000 | $17.99 | 8,000 | D | — | — | |
| 2 | Common | Ordinary Shares | 2021-08-24 | S | D | 8,000 | $143.36 | 0 | D | — | — | |
| 3 | Common | Ordinary Shares | 2021-08-24 | M | A | 8,000 | $17.99 | 8,000 | D | — | — | |
| 4 | Common | Ordinary Shares | 2021-08-23 | S | D | 8,000 | $135.00 | 0 | D | — | — | |
| 5 | Derivative | Stock Options (Right to Buy) | 2021-08-23 | M | D | 8,000 | $0.00 | 38,000 | D | $17.99 · — to 2028-11-16 | 8,000 Ordinary Shares | (F2) The options vest in equal annual installments over five years beginning on 11/16/2019, the first anniversary of the date of grant. |
| 6 | Derivative | Stock Options (Right to Buy) | 2021-08-24 | M | D | 8,000 | $0.00 | 30,000 | D | $17.99 · — to 2028-11-16 | 8,000 Ordinary Shares | (F2) The options vest in equal annual installments over five years beginning on 11/16/2019, the first anniversary of the date of grant. |